HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marc Ferrer Selected Research

Lysosomal Storage Diseases (Lysosomal Storage Disease)

11/2016Cell-based high-throughput screening identifies galactocerebrosidase enhancers as potential small-molecule therapies for Krabbe's disease.
1/2016Disease models for the development of therapies for lysosomal storage diseases.
1/2011Novel patient cell-based HTS assay for identification of small molecules for a lysosomal storage disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marc Ferrer Research Topics

Disease

47Neoplasms (Cancer)
04/2023 - 12/2006
10Infections
01/2024 - 04/2015
7Neoplasm Metastasis (Metastasis)
01/2022 - 01/2013
6Alzheimer Disease (Alzheimer's Disease)
11/2023 - 05/2005
6ST Elevation Myocardial Infarction
09/2023 - 12/2017
5COVID-19
12/2022 - 06/2021
5Inflammation (Inflammations)
12/2022 - 09/2009
5Ovarian Neoplasms (Ovarian Cancer)
08/2021 - 01/2017
4Virus Diseases (Viral Diseases)
12/2022 - 12/2019
4Melanoma (Melanoma, Malignant)
01/2020 - 01/2013
4Breast Neoplasms (Breast Cancer)
11/2018 - 12/2003
3Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
01/2024 - 01/2008
3Pancreatic Neoplasms (Pancreatic Cancer)
01/2023 - 01/2018
3Human Influenza (Influenza)
12/2022 - 01/2019
3Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
01/2020 - 01/2017
3Rhabdomyosarcoma
01/2018 - 01/2017
3Lysosomal Storage Diseases (Lysosomal Storage Disease)
11/2016 - 01/2011
3Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
08/2014 - 06/2012
2Neurilemmoma (Schwannoma)
01/2023 - 01/2021
2Meningioma (Meningiomas)
01/2023 - 01/2021
2Ventricular Fibrillation
12/2022 - 01/2018
2Personality Disorders (Personality Disorder)
08/2022 - 09/2016
2Neurofibrosarcoma (MPNST)
01/2022 - 07/2020
2Carcinogenesis
01/2021 - 01/2017
2Starvation
01/2020 - 03/2015
2Prostatic Neoplasms (Prostate Cancer)
01/2019 - 11/2017
2Disease Progression
01/2019 - 01/2017
2Sarcoma (Soft Tissue Sarcoma)
01/2018 - 12/2017
2Mood Disorders (Mood Disorder)
04/2017 - 12/2010
2Fibrosarcoma
11/2016 - 01/2013
2Globoid Cell Leukodystrophy (Krabbe Disease)
11/2016 - 03/2013
2Neurologic Manifestations (Neurological Manifestations)
11/2016 - 03/2013
2Colonic Neoplasms (Colon Cancer)
10/2016 - 11/2008
2Leukemia
10/2015 - 01/2013
2Heart Failure
01/2015 - 01/2013
2Borderline Personality Disorder (Personality Disorders, Borderline)
10/2014 - 03/2012
2Insulin Resistance
01/2012 - 03/2009
1Status Epilepticus (Complex Partial Status Epilepticus)
04/2024
1Seizures (Absence Seizure)
04/2024

Drug/Important Bio-Agent (IBA)

23Proteins (Proteins, Gene)FDA Link
01/2024 - 11/2006
9Antiviral Agents (Antivirals)IBA
10/2023 - 04/2015
7Biomarkers (Surrogate Marker)IBA
01/2024 - 08/2015
5Phosphotransferases (Kinase)IBA
04/2024 - 08/2014
5Drug CombinationsIBA
12/2020 - 10/2012
4Peptides (Polypeptides)IBA
11/2019 - 05/2005
4Transcription Factors (Transcription Factor)IBA
01/2018 - 03/2015
3Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2023 - 01/2017
3RNA (Ribonucleic Acid)IBA
01/2023 - 06/2020
3CytokinesIBA
12/2022 - 09/2009
3RelaxinIBA
11/2019 - 01/2013
3Mitogen-Activated Protein KinasesIBA
01/2018 - 01/2017
3EnzymesIBA
11/2016 - 06/2008
3Amyloid beta-PeptidesIBA
10/2016 - 05/2005
3Amyloid (Amyloid Fibrils)IBA
10/2016 - 11/2006
3navitoclaxIBA
02/2016 - 01/2013
3InterferonsIBA
04/2015 - 12/2011
3Small Interfering RNA (siRNA)IBA
01/2013 - 12/2006
2ProteomeIBA
01/2024 - 12/2022
2Sirolimus (Rapamycin)FDA Link
04/2023 - 01/2021
28- (6- methoxypyridin- 3- yl)- 3- methyl- 1- (4- piperazin- 1- yl- 3- trifluoromethylphenyl)- 1,3- dihydroimidazo(4,5- c)quinolin- 2- oneIBA
04/2023 - 01/2022
2Interleukin-6 (Interleukin 6)IBA
12/2022 - 12/2022
2Interleukin-10 (Interleukin 10)IBA
12/2022 - 09/2009
2NucleosidesIBA
01/2022 - 06/2021
2pyrimidineIBA
01/2022 - 06/2021
2Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 11/2018
2remdesivirIBA
01/2022 - 06/2021
2LipidsIBA
12/2021 - 01/2020
2MicroRNAs (MicroRNA)IBA
01/2021 - 12/2018
2Oxidoreductases (Dehydrogenase)IBA
01/2021 - 08/2015
2LuciferasesIBA
03/2020 - 01/2013
2DystrophinIBA
01/2020 - 01/2017
2AntigensIBA
01/2020 - 12/2016
2Histones (Histone)IBA
11/2019 - 01/2019
2Therapeutic UsesIBA
11/2019 - 01/2015
2Growth Differentiation Factor 15IBA
10/2019 - 01/2019
2Messenger RNA (mRNA)IBA
01/2019 - 12/2018
2metarrestinIBA
12/2018 - 01/2018
2Cocaine (Cocaine HCl)IBA
01/2018 - 04/2017
2Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
01/2018 - 01/2017
2trametinibIBA
01/2018 - 01/2018
2BenzodiazepinesIBA
04/2017 - 12/2010
2TOR Serine-Threonine KinasesIBA
01/2017 - 03/2015
2AcidsIBA
01/2017 - 09/2012
2ChromatinIBA
01/2017 - 11/2008
2Estrogen Receptor alphaIBA
12/2016 - 12/2003
2DNA (Deoxyribonucleic Acid)IBA
11/2016 - 06/2012
2GalactosylceramidaseIBA
11/2016 - 03/2013
2propylene diquat (PDQ(+))IBA
09/2016 - 03/2012
2CateninsIBA
05/2016 - 01/2013
2chlorcyclizineIBA
02/2016 - 04/2015
2ruxolitinibIBA
02/2016 - 10/2015
2Phosphoric Monoester Hydrolases (Phosphatases)IBA
06/2014 - 01/2013
2Lysergic Acid Diethylamide (LSD)IBA
09/2012 - 01/2011
2Insulin (Novolin)FDA Link
01/2012 - 03/2009
2LipopolysaccharidesIBA
12/2011 - 09/2009
1Pilocarpine (Ocusert)FDA LinkGeneric
04/2024

Therapy/Procedure

34Therapeutics
04/2023 - 12/2003
9Drug Therapy (Chemotherapy)
01/2023 - 06/2012
4Percutaneous Coronary Intervention
09/2023 - 12/2017
2Immunotherapy
01/2020 - 12/2016